The Valley Desk

ArticleJournal of psoriasis and psoriatic arthritisPublished

Icotrokinra, a Targeted Oral Peptide, in Participants With Moderate-to-Severe Plaque Psoriasis and Self-Reported Psoriatic Arthritis: Results From a Pooled Analysis of the Phase 3 ICONIC-LEAD, ICONIC-ADVANCE 1, and ICONIC-ADVANCE 2 Trials

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, with Drexel University linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Journal of psoriasis and psoriatic arthritis
Published
Subject terms
Psoriatic Arthritis; Plaque Psoriasis; Patient-reported Outcomes; Interleukin-23 Receptor; Oral Peptide; Interleukin-23 Inhibition; Icotrokinra
PubMed ID
42898453
PubMed Central ID
PMC13677984
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal